Bad pharma data can have a cost which is frequently not what organisations appreciate. Mistakes can impact on investments, sourcing, market expansion, licensing and competitive positioning. In a business where choices are made on a huge level of monetary and operational investment, having reliable intelligence is not an option.
More Info:
https://www.lifescienceinte ...